Clinical Trial

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction and 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-07-29; most recent amendment 2025-09-04.
Status change: Recruiting → Active, Not Recruiting 2022-10-25
Trial Details
NCT Number NCT04037605
Lead Sponsor Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Conditions Sleep Restriction
Enrollment 5 participants
Start Date 2020-02-09
Primary Completion 2022-07-24 (estimated)
Study Completion 2026-06-24 (estimated)
Updated on ClinicalTrials.gov 2025-09-11